scispace - formally typeset
Y

Yang Sun

Researcher at Nanjing University

Publications -  347
Citations -  15680

Yang Sun is an academic researcher from Nanjing University. The author has contributed to research in topics: Medicine & Apoptosis. The author has an hindex of 45, co-authored 306 publications receiving 12334 citations. Previous affiliations of Yang Sun include Shanghai Jiao Tong University & Shanghai University.

Papers
More filters
Journal ArticleDOI

Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

Daniel J. Klionsky, +2522 more
- 21 Jan 2016 - 
TL;DR: In this paper, the authors present a set of guidelines for the selection and interpretation of methods for use by investigators who aim to examine macro-autophagy and related processes, as well as for reviewers who need to provide realistic and reasonable critiques of papers that are focused on these processes.
Journal ArticleDOI

Muscle fatigue: general understanding and treatment

TL;DR: Studies on muscle fatigue are summarized, including topics such as the sequence of events observed during force production, in vivo fatigue-site evaluation techniques, diagnostic markers and non-specific but effective treatments.
Journal ArticleDOI

Protective effects of salidroside on hydrogen peroxide-induced apoptosis in SH-SY5Y human neuroblastoma cells.

TL;DR: The results suggest that salidroside has protective effects against oxidative stress-induced cell apoptosis, which might be a potential therapeutic agent for treating or preventing neurodegenerative diseases implicated with oxidative stress.
Journal ArticleDOI

Small molecule-driven mitophagy-mediated NLRP3 inflammasome inhibition is responsible for the prevention of colitis-associated cancer

TL;DR: It is shown that the small molecule andrographolide (Andro) protects mice against azoxymethane/dextran sulfate sodium-induced colon carcinogenesis through inhibiting the NLRP3 inflammasome, and is responsible for the prevention of CAC.
Journal ArticleDOI

MicroRNA-124 mediates the cholinergic anti-inflammatory action through inhibiting the production of pro-inflammatory cytokines

TL;DR: It is found that miR-124 is upregulated by cholinergic agonists in LPS-exposed cells and mice and is a potential therapeutic target for the treatment of inflammatory diseases.